[PDF] Top 20 Derechos humanos y diversidad sexual en Nicaragua
Has 10000 "Derechos humanos y diversidad sexual en Nicaragua" found on our website. Below are the top 20 most common "Derechos humanos y diversidad sexual en Nicaragua".
Management options for the treatment of benign prostatic hyperplasia with or without erectile dysfunction: a focus on tadalafil and patient considerations
... and erectile dysfunction increase with ...will focus on the potential use and clinical significance of phosphodiesterase-5 inhibitors in the treatment of LUTS secondary to benign ... See full document
15
Treatment satisfaction among men with concurrent benign prostatic hyperplasia and erectile dysfunction treated with tadalafil or other phosphodiesterase type-5 inhibitor combinations
... current treatment group comparisons among men with BPH/LUTS and ED ...on treatment satisfaction of BPH/LUTS or ED tend to focus on disease-specific ...of treatment satisfaction, the TSQM-9, ... See full document
5
The use of a single daily dose of tadalafil to treat signs and symptoms of benign prostatic hyperplasia and erectile dysfunction
... of benign prostatic hyperplasia (LUTS/BPH) and erectile dysfunction (ED) has been widely evidenced in several clinical epidemiologic ...the treatment of LUTS/BPH and ED has been ... See full document
5
Men’s preferences for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia: a discrete choice experiment
... pharmacological treatment options available to men with ...ticular focus on reducing urgency of urination combined with reducing night-/daytime frequency is likely to provide the highest benefit for ... See full document
11
Combination of tadalafil and finasteride for improving the symptoms of benign prostatic hyperplasia: critical appraisal and patient focus
... prior erectile dysfunction in the combination therapy group demonstrated improvement in sexual desire, erectile function, orgasmic function, and overall satisfaction with ...with tadalafil ... See full document
73
AN AYURVEDIC APPROACH IN THE MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA .......
... The patients for the research were selected from Department of Shalya- Tantra OPD, M.S.M. Institute of Ayurveda, B.P.S. Mahila Vishwavidyalaya, Khanpur- Kalan, Haryana. Established and diagnosed patients satisfying ... See full document
6
Tadalafil in the treatment of erectile dysfunction; an overview of the clinical evidence
... h, tadalafil could provide nearly continuous coverage when taken on a regular basis, allowing patients and their partners to choose freely when to have sexual activities without the need of timing ...of ... See full document
6
Benign prostatic hyperplasia and new treatment options – a critical appraisal of the UroLift system
... obstructing prostatic tissue under direct ...the prostatic tissue so as to open the prostatic urethral ...outer prostatic capsule to the inner urethral wall when compressed by the delivery ... See full document
6
Current and emerging treatment options for Peyronie's disease
... (greater than 60 degrees), multiple areas of plaque, or those without adequate penile length are candidates for incision and grafting. Similar to penile plication, the penis is degloved exposing Buck’s fascia. The ... See full document
8
Silodosin for the treatment of clinical benign prostatic hyperplasia: safety, efficacy, and patient acceptability
... of this clinical trial was to confirm that silodosin is superior to the placebo and not inferior to tamsulosin at a daily dose of 0.2 mg. The inclusion criteria were men aged $50 years with an International Prostate ... See full document
49
A COMPARATIVE STUDY ON SHAMANA AND SANSHODHAN TREATMENT IN MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA .......
... were without indwelling catheter. Group treatment in form of Vasti karma and Group B was administered Varun quatha 50ml BD and Shudha kupeelu 125ml BD with honey and ... See full document
25
A phosphodiesterase 5 inhibitor, tadalafil, suppresses stromal predominance and inflammation in a rat model of nonbacterial prostatitis
... as tadalafil, are effective for the treatment of LUTS/BPH [5, 6], and have been acknowledged in the recent guidelines published by the Japanese Urological Association [7] and the European Association of ... See full document
8
MEDICAL TREATMENT OF BENIGN PROSTATIC HYPERPLASIA AFTER CYSTOLITHOTRIPSY
... medical treatment of BPH which developed in the past few decades lead to decrease IPSS by 30-40 percentage (7) and also the risk of surgical operation in patient with BPH or attack of acute urine retention ... See full document
12
Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia
... Results: We identified 12 adverse events or complications; rates were similar in both groups. No PVP patient required a blood transfusion; 5%–11% of TURP patients did. PVP patients had a significantly lower ... See full document
7
2010 Update: Guidelines for the management of benign prostatic hyperplasia
... male patient over 50 years of age, presenting with lower urin- ary tract symptoms (LUTS) believed to be associated with benign prostatic obstruction ...different treatment ... See full document
20
Intravescical prostatic protrusion is a predictor of alpha blockers response: results from an observational study
... coming from our study suggest that IPP is significantly and inversely correlated with treatment success in patients affected by BPE and with LUTS under alpha-blocker ther- apy. Alpha-blockers odd ratio of success ... See full document
16
Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia
... first treatment period, both drugs significantly improved the total IPSS score, but the improvement on silodosin was significantly superior to that on ...crossover treatment, significant improvement was ... See full document
22
Finasteride in the treatment of patients with benign prostatic hyperplasia: a review
... group differences between finasteride and placebo were not statistically significant for AUA Symptom Index, Symptom Problem Index, BPH Impact Index, and peak flow rate. In contrast, the mean differences between terazosin ... See full document
17
Management of benign prostatic hyperplasia with silodosin
... the treatment of BPH in two randomized, placebo-controlled, phase III ...of treatment, patients receiv- ing silodosin showed significant improvement in total IPSS (difference − ... See full document
23
A Prospective study of Sexual Dysfunction in Patients with Benign Prostatic Hyperplasia
... Out of a total of 218 patients who were enrolled into the study, 120 were finally included in the study after applying the inclusion and exclusion criteria. Though the sample size appears low, the patient group ... See full document
12
Related subjects